Mapping New Markets: How Quotient Sciences Accelerated European Biopharma Penetration with Zymewire
Zymewire's data has been integral in the development of a global AI workflow
Quotient selected Zymewire to optimise commercial processes prior to embarking on a range of new market initiatives.
"It's important to have early insight into which accounts in designated territories, particularly net-new ones, are being funded and progressing to the next development stage to ensure timely commercial engagement."
"We're running a seminar in Philadelphia and need to find local prospects to invite, both from new accounts and existing clients so we can continue to expand our reach and grow local relationships."
"The marketing team was targeting one set of prospects through LinkedIn advertising, while the BD team prioritized a different group for direct outreach, each relying on separate data sources. A centralized source of truth would better align our efforts and drive more meaningful customer conversations."
"Poor and cumbersome CRM integration hindered the accessibility of clarified and accurate data, resulting in time lost when accessing internal account activity, while also lowering ROI by paying for a resource unfulfilled."
Zymewire Pro Edition with Zoudini
The Quotient Sciences Commercial Team implemented Zymewire's Pro Edition with Zoudini, equipping 35 stakeholders with access. This edition allowed for native integration with the CRM (Salesforce), enabling the Quotient Sciences Commercial team to rapidly pair Zymewire's AI-driven real-time market insights with their internal CRM account data to quickly deploy messaging across target accounts.
Business Development and Sales stakeholders gained the ability to proactively message against high-priority biopharma targets based on daily triggers, significantly improving their speed-to-action.
Marketing stakeholders were able to develop multiple, niche campaigns with a single click, supporting both global messaging efforts and targeting local regions.
Commercial Leadership gained a central ground-truth data set on which to make prioritization decisions to better align team efforts toward a common and more impactful goal.
The native CRM (Salesforce) integration facilitated net-new biopharma discovery, the ability to log accounts/leads directly to Salesforce, visibility into internal account activity within Zymewire.
Impact across the commercial team
Particularly in new market penetration of biologics for a specific service line, Zymewire was integral in understanding our TAM and SAM, leading to 8 new enquiries (potential opportunity leads), with 7 meetings conducted, and a ballpark proposal issued.
Operationalization of Zymewire takes place at the territory level through centralized meetings with actions for account prioritization and outreach. Increased awareness of buying signals from week to week has aided in orienting and aligning account progress throughout the territory across service lines.
Key buying criteria
High specificity of account level data
Proactive identification of real time company triggers (funding, pipeline, hiring)
Ability to rapidly build and execute targeted, campaign driven account lists
Strong usability and ease of integration into existing commercial workflows
Native CRM integration enabling alignment with internal Salesforce data
Flexibility to segment by geography, modality, indication, and trigger events
Enables coordinated campaign execution across Inside Sales, BD, and Marketing teams
Quotient Sciences on working with Zymewire
Zymewire has added significant value to our commercial strategy by enabling more focused, data-driven campaigns while reducing manual effort. The high specificity of account level data is a clear differentiator, giving our teams deeper visibility into pipelines and allowing us to prioritize outreach with greater precision and confidence.
Quotient selected Zymewire to strengthen our ability to identify and engage emerging biotech companies and execute targeted campaigns across Europe and globally. The platform enables rapid development of highly relevant account lists, which is especially valuable in fragmented European markets. Additionally, Zymewire's data has been integral in the development of a global AI workflow providing static account data into a system designed to automate and create efficiencies across the commercial organization.
Since implementation, our European teams have successfully delivered targeted campaigns aligned to funding milestones, pipeline developments, and modality specific opportunities, resulting in stronger engagement with priority accounts. Zymewire has also improved coordination across Inside Sales and Business Development, and is now a core component of how we drive campaign and territory-led growth across Europe while supporting broader global expansion.